comparemela.com

Latest Breaking News On - Dilutive funding through nj economic development program - Page 1 : comparemela.com

Palatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

Phase 3 PL9643 Data in Patients with Dry Eye Disease Presented at KOL Event Analysis of Lead-In Population of Initial 120 Patients Showed Statistical.

United statesNew jerseyCarl spanaPrnewswire palatin technologies incSecurities exchangeJersey economic development authorityPalatin technologies incDilutive funding through nj economic development programJersey technology business tax certificate transfer programAssociation of researchInternational journal of molecular sciencesDry eye disease presentedLead in populationShowed statistical separationClinical efficacy across multiple signsDry eye

Palatin Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease Ongoing Patient Enrollment on Track Topline Results Currently Expected Mid-Calendar Year 2023.

New jerseyUnited statesState of new jerseyCarl spanaFosun pharmaJersey economic development authorityPalatin technologies incDilutive funding through nj economic development programPrnewswire palatin technologies incSecurities exchangeJersey technology business tax certificate transfer programDry eye disease ongoingResults currently expected mid calendarUlcerative colitis commencedInterim analysis targetedFirst half calendar year

vimarsana © 2020. All Rights Reserved.